Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Free Articles

Week in Review: Everest Announces Two In-Licensings with Total Value of $1 Billion
Cue Health Plans $180 Million US IPO for Home Healthcare Platform
Everest in $500 Million Deal for mRNA Products, including COVID-19 Vaccine
Week in Review: Sanofi Acquires Kadmon, a US-China Pharma, for $1.9 Billion
Brii Bio Allocates $100 Million to Bring Dual SARS-CoV-2 mAb Therapy to Market
ChinaBio Event
Shanghai and Digital
May 10-14, 2021
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China